scholarly journals Socio-demographic Determinants of Low Sexual Desire and Hypoactive Sexual Desire Disorder: A Population-based Study in Iran

2020 ◽  
Author(s):  
Zeinab Hamzehgardeshi ◽  
Mina Malary ◽  
Mahmood Moosazadeh ◽  
Soghra Khani ◽  
Mehdi Pourasghar

Abstract Background: Various socio-demographic factors are determinants of Low Sexual Desire (LSD), but whether these are the determinants of Hypoactive Sexual Desire Disorder (HSDD) are unclear. The aim of this study is to evaluate the Socio-demographic determinants of LSD and HSDD in Iranian women of reproductive age.Methods: This was a population-based, cross-sectional study of 1000 Iranian women of reproductive age (15-49 years) who met the inclusion criteria and were chosen through systematic random sampling from all the healthcare centers in Sari, Iran. LSD was defined as a score no higher than 33 on the Sexual Interest and Desire Inventory-Female (SIDI-F); sexually related personal distress was defined as a score of at least 11.0 on the Female Sexual Distress Scale–Revised (FSDS-R); and HSDD was defined as a combination of these scores. Descriptive statistics were used to describe demographic characteristics while for analyzing grouped variables, chi-square test was applied. Multivariate regression test was also used to adjust the effect of confounding variables. Results: The mean score of sexual interest/desire among women who referred to healthcare centers in the city of Sari is estimated as 30.6±10.5. After adjusting the effect of the confounder variables by logistic regression multivariate analysis, the age at first intercourse, the length of time spent in marriage, and the level of satisfaction with income were variables significantly associated with LSD and HSDD (P < .01). Although increasing individual′s age (P < .001) and body mass index (P < .01) were predictors of LSD in women, HSDD was not statistically significant.Conclusion: There are some factors that are associated with LSD in women but are not related to HSDD. In other words, some factors associated with LSD do not cause personal distress which are one of the criteria necessary for HSDD.

2020 ◽  
Author(s):  
Zeinab Hamzehgardeshi ◽  
mina malary ◽  
mahmood moosazadeh ◽  
Soghra Khani ◽  
mehdi Pourasghar ◽  
...  

Abstract Background: Various socio-demographic factors have been introduced as the determinants of Low Sexual Desire (LSD), but whether these variables can also contribute to the Hypoactive Sexual Desire Disorder (HSDD), remains uncertain. In this study, we sought to identify the socio-demographic determinants of LSD and HSDD in Iranian women of reproductive age. Methods: This was a population-based, cross-sectional study of 1000 married Iranian women of reproductive age (16-49 years) who met the inclusion criteria. The participants were chosen using the systematic random sampling method from all the healthcare centres in the city of Sari, Iran. LSD was defined as a score no higher than 33 on the Sexual Interest and Desire Inventory-Female (SIDI-F). The sexually-related personal distress was considered as a score of at least 11.0 on the Female Sexual Distress Scale-Revised (FSDS-R), and HSDD was determined based on the sum of those scores. Descriptive statistics were used to describe the socio-demographic characteristics and a chi-square test was run for data analysis using grouping variables. Multivariate logistic regression test was also employed to adjust the effect of confounding variables. Results: The mean score of sexual interest/desire among women was 30.6±10.5. After adjusting the effect of confounding variables, logistic regression showed that socio-demographic variables including age at first intercourse, length of marriage and the level of satisfaction with income were significantly associated with both LSD and HSDD (P<0.01). While advancing age (P<0.001) and body mass index (P<0.01) were just predictors of LSD. Conclusion: Some socio-demographic factors could predict LSD in women, while they were not associated with HSDD. In other words, some factors associated with LSD do not instigate sexually-related personal distress, which is one of the criteria necessary for the diagnosis of HSDD.


2020 ◽  
Author(s):  
Zeinab Hamzehgardeshi ◽  
mina malary ◽  
mahmood moosazadeh ◽  
Soghra Khani ◽  
mehdi Pourasghar

Abstract Background: Various socio-demographic factors have been introduced as determinants of low sexual desire (LSD), but whether these variables can also contribute to hypoactive sexual desire disorder (HSDD) remains uncertain. In this study, we sought to identify the socio-demographic determinants of LSD and HSDD in Iranian women of reproductive age. Methods: This was a population-based, cross-sectional study of 1000 Iranian women of reproductive age (15-49 years) who met the inclusion criteria. The participants were chosen using the systematic random sampling method from all the healthcare centers in Sari, Iran. LSD was defined as a score no higher than 33 on the Sexual Interest and Desire Inventory-Female (SIDI-F), sexually-related personal distress was considered as a score of at least 11.0 on the Female Sexual Distress Scale–Revised (FSDS-R), and HSDD was determined based on the sum of these scores. Descriptive statistics were used to describe the socio-demographic characteristics, while for analyzing grouped variables, Chi-squared test was run. Multivariate logistic regression test was also employed to adjust the effect of confounding variables. Results: The mean score of sexual interest/desire among women was 30.6±10.5. After adjusting for the effect of confounding variables (socio-demographic variables such as age, age at first intercourse, level of education, etc.), logistic regression showed that age at first intercourse, length of marriage, and the level of satisfaction with income were significantly associated with both LSD and HSDD (P<0.01). In addition, advancing age (P<0.001) and body mass index (P<0.01) were predictors of LSD alone. Conclusion: Some socio-demographic factors could predict LSD in women, while they were not associated with HSDD. In other words, some factors associated with LSD do not instigate personal distress, which is one of the criteria necessary for the diagnosis of HSDD.


2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Zeinab Hamzehgardeshi ◽  
Mina Malary ◽  
Mahmood Moosazadeh ◽  
Soghra Khani ◽  
Mehdi Pourasghar ◽  
...  

Abstract Background Various socio-demographic factors have been introduced as the determinants of Low Sexual Desire (LSD), but whether these variables can also contribute to the Hypoactive Sexual Desire Disorder (HSDD), remains uncertain. In this study, we sought to identify the socio-demographic determinants of LSD and HSDD in Iranian women of reproductive age. Methods This was a population-based, cross-sectional study of 1000 married Iranian women of reproductive age (16–49 years) who met the inclusion criteria. The participants were chosen using the systematic random sampling method from all the healthcare centres in the city of Sari, Iran. LSD was defined as a score no higher than 33 on the Sexual Interest and Desire Inventory-Female (SIDI-F). The sexually-related personal distress was considered as a score of at least 11.0 on the Female Sexual Distress Scale-Revised (FSDS-R), and HSDD was determined based on the sum of those scores. Descriptive statistics were used to describe the socio-demographic characteristics and a chi-square test was run for data analysis using grouping variables. Multivariate logistic regression test was also employed to adjust the effect of confounding variables. Results The mean score of sexual interest/desire among women was 30.6 ± 10.5. After adjusting the effect of confounding variables, logistic regression showed that socio-demographic variables including age at first intercourse, length of marriage and the level of satisfaction with income were significantly associated with both LSD and HSDD (P < 0.01). While advancing age (P < 0.001) and body mass index (P < 0.01) were just predictors of LSD. Conclusion Some socio-demographic factors could predict LSD in women, while they were not associated with HSDD. In other words, some factors associated with LSD do not instigate sexually-related personal distress, which is one of the criteria necessary for the diagnosis of HSDD.


2010 ◽  
Vol 17 (6) ◽  
pp. 1114-1121 ◽  
Author(s):  
Carmita H.N. Abdo ◽  
Ana L.R. Valadares ◽  
Waldemar M. Oliveira ◽  
Marco T. Scanavino ◽  
João Afif-Abdo

2010 ◽  
Vol 7 (12) ◽  
pp. 3918-3928 ◽  
Author(s):  
Anita H. Clayton ◽  
David Goldmeier ◽  
Rossella E. Nappi ◽  
Glen Wunderlich ◽  
Diane J. Lewis-D'Agostino ◽  
...  

2017 ◽  
Vol 8 (1) ◽  
pp. 16-25 ◽  
Author(s):  
Faina Gelman ◽  
Jessica Atrio

The pathophysiology, diagnosis and treatment of female sexual interest in pre- and post-menopausal women present a complex arena for patients and physicians to navigate. Flibanserin was the first pharmacologic treatment, approved by the United States Food and Drug Administration in August 2015, for hypoactive sexual desire disorder (HSDD) in premenopausal women. Side effects, contraindications and lack of approval in postmenopausal women are all limitations, as are issues surrounding patient and physician knowledge and access. Testosterone, buspirone, sildenafil, bupropion, bremelanotide, as well as herbal medications (Herbal vX or Tribulus terrestris) have demonstrated some clinical benefit in women with sexual dysfunction disorders however, trials have significant design, dosing or generalizability limitations. Nonpharmaceutical cognitive behavioral therapy, mindfulness meditation, pelvic floor therapy, and clitoral stimulators are also interventions women may pursue. This manuscript will explore the clinical data regarding these therapeutic modalities so as to bring attention to this issue of female HSDD, to offer an overview of current research, and to incite providers to initiate discussion among themselves and their patients.


2005 ◽  
Vol 1 (2) ◽  
pp. 263-277 ◽  
Author(s):  
Sheila Y Bolour ◽  
Glenn D Braunstein

Hypoactive sexual desire disorder is the most common cause of sexual dysfunction in women. According to a national survey, approximately a third of all women experience low sexual desire. The etiology of the disorder is often multifactorial. Research in treatment options for hypoactive sexual desire disorder is limited. In this article, treatment options including sex therapy, hormone therapy (estrogen, testosterone, dehydroepiandrosterone, tibolone), non-hormonal medical therapies (buproprion, buspirone, phosphodiesterase-5 inhibitors, amantadine and apomorphine) and herbal therapies (Avlimil®, Arginmax®, Zestra®, yohimbine and Ginkgo biloba) are reviewed.


Sign in / Sign up

Export Citation Format

Share Document